Ordering
Available Variants5 mg
CHA.78367-5mg
Price
€96.80
Available – Dispatch in 14 days
25 mg
CHA.78367-25mg
Price
€387.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.78367-5mg | €96.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.78367-25mg | €387.20 |
≥97% (HPLC), γ-secretase inhibitor , powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C26H23F2N3O4 |
|---|---|
| CAS Number | 209984-57-6 |
| Molecular Weight | 479.48 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329825453 |
| NACRES | NA.77 |
| MDL number | MFCD09832551 |
| Assay | ≥97% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
LY-411575, also known by its CAS number 209984-57-6, is a potent and selective gamma-secretase inhibitor that has been investigated for its potential therapeutic applications. Gamma-secretase is a multi-subunit enzyme complex that plays a crucial role in the processing of amyloid precursor protein, resulting in the production of amyloid-beta peptides, which are implicated in the pathogenesis of Alzheimers disease. By inhibiting gamma-secretase, LY-411575 has been shown to reduce the production of amyloid-beta peptides in vitro and in vivo, suggesting its potential as a treatment for Alzheimers disease. Further research is needed to fully elucidate the pharmacological properties and therapeutic potential of LY-411575, but its selective inhibition of gamma-secretase makes it an interesting candidate for the treatment of this devastating neurodegenerative disorder. Its mechanism of action and efficacy are being further explored in preclinical studies.
